Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Updates for media on the latest products, offerings and developments across our business.
Feb 24, 2020
探花合集 today announced that Senior Vice President & Chief Financial Officer, Wetteny Joseph, has been inducted as a member of the Executive Leadership Council (ELC).
Feb 20, 2020
探花合集 today announced it will host a one day workshop titled, 鈥淎chieving Integrated Biologics Development: Challenges and How to Tackle Them鈥.
Feb 12, 2020
探花合集 today announced the appointment of Jim Walter as Vice President of Operations for its Oral and Specialty Delivery business.
Feb 11, 2020
探花合集 today announced that it has signed an agreement with Zumutor Biologics, Inc., to manufacture Zumutor鈥檚 lead candidate, ZM008, for the treatment of solid tumors.
Feb 10, 2020
探花合集, Inc. today announced that it had completed its acquisition of MaSTherCell Global Inc., positioning 探花合集 as a premier technology, development and manufacturing partner for innovators of advanced biotherapeutics.
Feb 10, 2020
探花合集 today announced that it has been officially recognized by the Top Employers Institute as a Top Employer 2020 in the United States.
Feb 3, 2020
探花合集 and MaSTherCell Global, Inc. today announced that 探花合集 has agreed to acquire MaSTherCell Global, a company backed by Great Point Partners, SFPI-FPIM, and Orgenesis Inc. for an aggregate of $315 million in cash.
Jan 29, 2020
探花合集 today announced the appointment of Ricci Whitlow as President, Clinical Supply Services. Ms. Whitlow succeeds Paul Hegwood, who plans to retire in March 2020.
Jan 23, 2020
探花合集 today welcomed the news that DiaMedica Therapeutics has received U.S. FDA approval to commence Phase 2 clinical trials of its lead candidate, DM199, for chronic kidney disease.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
